STOCK TITAN

Charging Robotics sells 51% of Israel unit for $2.5M

(Very High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Charging Robotics Inc. (CHEV) has sold a controlling stake in its subsidiary Charging Robotics Ltd. in Israel to Clearmind Medicine Inc. Under a share purchase agreement dated August 31, 2026, Clearmind agreed to purchase 149 newly issued ordinary shares of Charging Israel for an aggregate $2.5 million, giving Clearmind 51% of Charging Israel’s share capital while the Company retains 49%. The implied price is $16,778 per share, and the cash consideration is paid directly to Charging Israel.

As a condition to closing, Clearmind also agreed to provide Charging Israel with a $1.5 million loan bearing 4.0% annual interest, maturing three years after the effective date, with automatic extension if Charging Israel lacks sufficient positive cash flow to repay at that time. The loan may be prepaid at any time without penalty and may be accelerated by Clearmind upon specified default events.

After the transaction, Charging Israel will cease to be a wholly owned and consolidated subsidiary; the Company will account for its 49% interest as an investment in an affiliate. Pro forma 2025 results show a $4.865 million gain on deconsolidation and net income attributable to the Company of $4.818 million, versus a historical loss, with basic and diluted earnings per share improving to $0.46.

Positive

  • $2.5 million equity investment goes directly into Charging Robotics Ltd., strengthening that subsidiary’s capital base while the parent retains a 49% stake.
  • Deconsolidation of Charging Robotics Ltd. yields a pro forma $4.865 million gain in 2025 and turns the Company’s 2025 result into net income of $4.818 million with EPS of $0.46.
  • The additional $1.5 million shareholder loan at 4.0% interest provides further funding to Charging Robotics Ltd., with flexible prepayment and automatic extension tied to cash flow.

Negative

  • Charging Robotics Inc. will lose control of Charging Robotics Ltd.; the subsidiary will no longer be consolidated, and future results will reflect only equity in earnings or losses from the 49% stake.
  • Pro forma statements show ongoing "equity in losses from investment in affiliate" totaling $0.627 million for 2025, indicating the affiliate continues to generate losses attributable in part to the Company.
  • The $1.5 million loan includes default triggers such as payment delays and insolvency events, creating potential acceleration risk for Charging Robotics Ltd. if its financial position weakens.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Equity investment in Charging Robotics Ltd. $2.5 million aggregate purchase price 149 ordinary shares purchased by Clearmind, giving it 51% ownership
Loan to Charging Robotics Ltd. $1.5 million principal at 4.0% interest Shareholder loan from Clearmind, maturing three years after effective date
Ownership stakes after transaction 51% Clearmind, 49% Charging Robotics Inc. Post-closing issued and outstanding share capital of Charging Robotics Ltd.
Implied share price for Charging Robotics Ltd. $16,778 per share Aggregate $2.5 million consideration for 149 newly issued ordinary shares
Gain on deconsolidation of subsidiary $4.865 million Pro forma year ended December 31, 2025
Pro forma net income attributable to Company (2025) $4.818 million Year ended December 31, 2025 after giving effect to Transaction
Basic and diluted EPS (2025 pro forma) $0.46 per share Year ended December 31, 2025, 10,509,347 weighted-average shares
Equity in losses from investment in affiliate (2025 pro forma) $0.627 million loss Year ended December 31, 2025, pro forma statement of comprehensive income
deconsolidation financial
"the Company ceased to have a controlling financial interest in Charging Israel and deconsolidated Charging Israel"
Deconsolidation occurs when a company stops combining another business’s financial results and balances with its own—usually because it no longer controls that business. For investors this matters because it can suddenly shrink reported revenue, assets, debt and profit, or create a one‑time gain or loss, changing how risky or profitable the remaining company appears; think of it like removing a roommate from a shared household budget and seeing your monthly totals change.
investment in affiliate financial
"Investment in affiliate ... 2,503"
non-controlling interests financial
"Non-controlling interests ... 3,519"
An ownership stake in a subsidiary held by outside shareholders rather than the parent company, representing the portion of that subsidiary’s assets and profits the parent does not control. For investors, it shows what part of consolidated earnings and equity belongs to others — like a roommate who owns part of a house — which affects how much value and profit per share are truly attributable to the parent company’s shareholders.
pro forma condensed combined financial information financial
"providing the following unaudited pro forma condensed combined financial information"
equity in losses from investment in affiliate financial
"Equity in losses from investment in affiliate ... (627)"
Article 11 of Regulation S-X regulatory
"prepared for illustrative purposes in accordance with Article 11 of Regulation S-X"

FAQ

What transaction did Charging Robotics Inc. (CHEV) announce with Clearmind Medicine Inc.?

Charging Robotics Ltd., a subsidiary of Charging Robotics Inc., agreed to issue and sell 149 ordinary shares to Clearmind Medicine Inc. for an aggregate $2.5 million, giving Clearmind 51% ownership and leaving the Company with a 49% stake.

How will the ownership of Charging Robotics Ltd. change for CHEV after the deal?

After closing, Clearmind will own 51% of Charging Robotics Ltd., and Charging Robotics Inc. will retain a 49% interest. Charging Robotics Ltd. will no longer be a wholly owned or consolidated subsidiary of the Company.

What are the key terms of the Clearmind loan to Charging Robotics Ltd.?

Clearmind agreed to provide a loan of $1.5 million to Charging Robotics Ltd., bearing 4.0% annual interest, maturing on the third anniversary of its effective date, with automatic extension if cash flow is insufficient and with prepayment allowed at any time without penalty.

How does the transaction affect CHEV’s pro forma 2025 earnings?

Pro forma 2025 financials show a $4.865 million gain on deconsolidation, leading to net income attributable to Charging Robotics Inc. of $4.818 million, compared with a historical net loss, and basic and diluted earnings per share of $0.46.

When are the transactions between CHEV and Clearmind expected to close?

The Company states the share purchase and loan transactions are expected to close concurrently during the week of September 7, 2026, subject to satisfaction or waiver of customary closing conditions, including payment of the purchase price and funding of the loan.

How does the transaction impact CHEV’s pro forma 2026 interim results?

For the six months ended June 30, 2026, pro forma net loss attributable to Charging Robotics Inc. is $0.715 million, compared with a reported net loss of $0.95 million, and basic and diluted loss per share improves from $(0.08) to $(0.06).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001459188 0001459188 2026-08-31 2026-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): August 31, 2026

 

CHARGING ROBOTICS INC.

(Name of Registrant as specified in its charter)

 

Delaware   001-42936   20-2274999

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

20 Raul Wallenberg Street
Tel Aviv, Israel
  6971916
(Address of Principal Executive Offices)   (Zip Code)

 

(+972) 54 642-0352

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 8.01 Other Events

 

On August 31, 2026, Charging Robotics Ltd. (“Charging Israel”), a wholly owned subsidiary Charging Robotics Inc. (the “Company”), entered into a share purchase agreement (the “Share Purchase Agreement”) with Clearmind Medicine Inc. (“Clearmind”), pursuant to which Clearmind agreed to purchase 149 ordinary shares of Charging Israel for an aggregate purchase price of $2.5 million. Following the closing of the transaction, Clearmind will own 51% of the issued and outstanding share capital of Charging Israel and the Company will retain a 49% ownership interest. The purchase price for the shares is $16,778 per share.

 

In connection with, and as a condition to, the closing under the Share Purchase Agreement, Charging Israel entered into a loan agreement (the “Loan Agreement”) with Clearmind pursuant to which Clearmind agreed to provide Charging Israel with a loan in the principal amount of $1.5 million. The loan bears interest at a rate of 4.0% per annum and, unless repaid earlier, matures on the third anniversary of the effective date of the Loan Agreement, subject to extension under certain circumstances set forth therein and as further described below.

 

The transactions contemplated by the Share Purchase Agreement and the Loan Agreement are expected to close concurrently during the week of September 7, 2026, subject to the satisfaction or waiver of customary closing conditions, including payment of the purchase price and funding of the loan.

 

Unless earlier repaid, the outstanding principal amount of the loan, together with accrued and unpaid interest, will become due and payable on the third anniversary of the effective date of the Loan Agreement. If, as of that date, Charging Israel has not generated positive cash flow from its operating and financing activities, together with available financing sources, sufficient to repay the outstanding loan amount, as reflected in its most recently completed financial statements prepared in accordance with IFRS, the repayment date will automatically be extended until the first date on which Charging Israel has generated such cash flow and available financing sources. During any extension period, the outstanding principal amount will continue to accrue interest at the rate of 4.0% per annum. Charging Israel may prepay all or any portion of the loan at any time without penalty, premium or other fee. The Loan Agreement provides that Clearmind may accelerate the loan following certain events of default, including a failure by Charging Israel to make a required payment within 15 business days after it becomes due, certain negotiations with creditors regarding a general readjustment or rescheduling of indebtedness, a general assignment or composition for the benefit of creditors, specified insolvency, liquidation, dissolution or reorganization proceedings, or the levy or enforcement of legal process against all or a material portion of Charging Israel’s property or assets.

 

Upon consummation of the transaction, the Company will cease to own a controlling interest in Charging Israel and Charging Israel will no longer be a wholly owned subsidiary of the Company. The Company expects to retain a 49% equity interest in Charging Israel following the closing of the transactions.

 

Upon consummation of the transaction, Charging Israel will cease to be a consolidated subsidiary of the Company. The Company is filing with this Current Report on Form 8-K unaudited pro forma condensed consolidated financial information giving effect to the transaction pursuant to Article 11 of Regulation S-X, which information is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

The foregoing descriptions of the Share Purchase Agreement and Loan Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, copies of which are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K and incorporated herein by reference.

 

Warning Concerning Forward Looking Statements

 

This Current Report contains statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. For example, this Current Report states that the transactions contemplated by the Share Purchase Agreement and the Loan Agreement (the “Transactions”) are expected to close during the week of September 7, 2026, subject to the satisfaction or waiver of customary closing conditions, including payment of the purchase price and funding of the loan. In fact, the closing of the Transactions is subject to various conditions and contingencies as are customary in transactions of such nature in the United States. These forward looking statements are based upon the Company’s present intent, beliefs or expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons which are beyond the Company’s control. For this reason, among others, you should not place undue reliance upon the Company’s forward looking statements. Except as required by law, the Company undertakes no obligation to revise or update any forward looking statements in order to reflect any event or circumstance that may arise after the date of this Current Report.

 

1

 

 

Item 9.01 Financial Statements and Exhibits.

 

(b) Pro Forma Financial Information

 

The unaudited pro forma condensed consolidated financial information of the Company giving effect to the transaction described in Item 8.01 of this Current Report on Form 8-K is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Form of Share Purchase Agreement, dated August 31, 2026, by and between Charging Robotics Ltd. and Clearmind Medicine Inc.
10.2   Form of Loan Agreement, dated August 31, 2026, by and between Charging Robotics Ltd. and Clearmind Medicine Inc.
99.1   Charging Robotics Inc. Unaudited Pro Forma Condensed Consolidated Financial Information
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

  

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Charging Robotics Inc.  
     
By: /s/ Meni Nachmias  
Name:  Meni Nachmias  
Title: Chief Executive  Officer  

 

Date: September 4, 2026

 

3

 

Exhibit 99.1

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

Introduction

 

We are providing the following unaudited pro forma condensed combined financial information to aid in the analysis of the financial effect of the transactions entered into on August 31, 2026 pursuant to a share purchase agreement between Charging Robotics Ltd. (“Charging Israel”), then a wholly owned subsidiary of Charging Robotics Inc. (the “Company”), and Clearmind Medicine Inc. (“Clearmind”). Pursuant to the share purchase agreement, Charging Israel issued and sold to Clearmind 149 newly issued ordinary shares for aggregate cash consideration of $2.5 million, which was paid directly to Charging Israel. Following the issuance, Clearmind owns 51% of the issued and outstanding share capital of Charging Israel, and the Company retains a 49% ownership interest in Charging Israel.

 

In connection with, and as a condition to, the closing, Clearmind agreed to fund a loan to Charging Israel in the principal amount of $1.5 million. The loan bears interest at a rate of 4.0% per annum and, unless earlier repaid, matures on the third anniversary of its effective date, subject to an automatic extension under the circumstances specified in the loan agreement. Charging Israel may prepay all or any portion of the loan at any time without penalty, premium or other fee.

 

As a result of the share issuance, the Company ceased to have a controlling financial interest in Charging Israel and deconsolidated Charging Israel. The completed share issuance and related loan are referred to collectively as the “Transaction”. Unless the context otherwise requires, the terms “we,” “us,” “our” and the “Company” refer to Charging Robotics Inc. and its consolidated subsidiaries after giving effect to the Transaction.

 

The transfer by Charging Israel to the Company, effective July 1, 2026, of Charging Israel’s 18.33% ownership interest in Revoltz Ltd. (“Revoltz”) was an internal reorganization that did not change the Company’s consolidated ownership interest in, or accounting for, Revoltz and therefore is not treated as a separate pro forma transaction. For purposes of presenting the pro forma financial information following the deconsolidation of Charging Israel, the Revoltz interest is reflected as though it had been held directly by the Company throughout the periods presented, without changing the historical date on which the Company obtained control of Revoltz.

 

The Unaudited Pro Forma Condensed Combined Financial Statements

 

The unaudited pro forma condensed combined balance sheet as of June 30, 2026 gives effect to the Transaction as if it had occurred on June 30, 2026. The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2026 and the year ended December 31, 2025 give effect to the Transaction as if it had occurred on January 1, 2025.

 

 

The unaudited pro forma condensed combined financial information is based on available information and assumptions that management believes are reasonable, has been prepared for illustrative purposes in accordance with Article 11 of Regulation S-X. The pro forma information is not necessarily indicative of the financial condition or results of operations that would have occurred had the Transaction been completed on the dates assumed, nor is it indicative of the Company’s future financial condition or results of operations. The transaction accounting is preliminary and may change as additional information becomes available; any such changes could be material.

 

The historical financial information of Charging Israel was derived from its unaudited financial statements as of and for the six months ended June 30, 2026 and its audited financial statements as of and for the year ended December 31, 2025. The historical financial information of the Company was derived from its unaudited condensed consolidated financial statements as of and for the six months ended June 30, 2026 and its audited consolidated financial statements as of and for the year ended December 31, 2025.

 

The unaudited pro forma condensed combined financial information should be read together with the Company’s audited and unaudited consolidated financial statements and related notes and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Adjustments to Unaudited Pro Forma Condensed Combined Financial Information

 

The historical consolidated financial statements have been adjusted to reflect the Transaction in accordance with U.S. GAAP. The material transaction accounting adjustments and related assumptions are described below.

 

Because Charging Israel was a wholly owned consolidated subsidiary through June 30, 2026, its balances and transactions with the Company were eliminated in the historical consolidated financial statements. The pro forma adjustments reflect the Company’s loss of control and deconsolidation of Charging Israel upon completion of the Transaction. The prior transfer of the 18.33% Revoltz interest to the Company was an internal reorganization and does not change Revoltz’s consolidated presentation.

 

No autonomous-entity or management adjustments have been presented. Pro forma basic and diluted earnings per share reflect the pro forma net income or loss attributable to the Company using the Company’s historical weighted-average shares outstanding because the Transaction did not involve the issuance or redemption of Company shares.

 

The unaudited pro forma transaction accounting adjustments included in the unaudited pro forma condensed combined balance sheet as of June 30, 2026, and the unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2026, and the year ended December 31, 2025, are as follows:

 

2

 

CHARGING ROBOTICS INC.

Unaudited Pro Forma Interim Condensed Consolidated Balance Sheet

As of June 30, 2026

U.S. dollars in thousands
(Except share and per share data)

 

   June 30,
2026
   Transaction
Accounting
Adjustments
   Notes   Pro Forma 
   (Unaudited)
ASSETS                
Current assets:                    
Cash  $10   $(2)   A   $8 
Loan to related party   -    1,494    C    1,494 
Other accounts receivable   336    (167)   A    169 
Total current assets   346    1,325         1,671 
                     
Non-current assets:                    
Investment in affiliate   -    2,503    B    2,503 
Intangible assets, net   6,672    -         6,672 
Goodwill   1,772    -         1,772 
Fixed assets, net   1    -         1 
Other non-current assets   36    -         36 
Total non-current assets   8,481    2,503         10,984 
                     
TOTAL ASSETS  $8,827   $3,828        $12,655 
                     
LIABILITIES & STOCKHOLDERS’ EQUITY                    
Current liabilities:                    
Accounts payable  $168   $(168)   A   $- 
Other current liabilities   1,145    (952)   A    193 
Short term loans   1,766    (604)   A, C    1,162 
Payables to related parties   177    (66)   A    111 
Total current liabilities   3,256    (1,790)        1,466 
                     
Non-current liabilities:                    
Deferred tax liability   1,534    -         1,534 
Other non-current liabilities   39    (39)   A    - 
Total non-current liabilities   1,573    (39)        1,534 
                     
Total liabilities  $4,829    (1,829)       $3,000 
                     
Stockholders’ equity                    
Preferred shares, par value $0.0001, 10,000,000 shares authorized, 0 shares issued and outstanding  $-   $-        $- 
Common stock, par value $0.0001, 50,000,000 shares authorized, 11,246,252 shares issued and outstanding at June 30, 2026 and December 31, 2025   1    -         1 
Additional paid-in capital   5,180    -         5,180 
Accumulated other comprehensive loss   (457)   467    A    10 
Accumulated equity (deficit)   (4,245)   5,190    A, B    945 
Total stockholders’ equity attributable to the Company   479    5,657         6,136 
Non-controlling interests   3,519    -         3,519 
Total stockholders’ equity   3,998    5,657         9,655 
                     
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $8,827   $3,828        $12,655 

 

3

 

CHARGING ROBOTICS INC.

Unaudited Pro Forma Interim Condensed Consolidated Statement of Comprehensive Loss
For the Six months ended June 30, 2026

U.S. dollars in thousands
(Except share and per share data)

 

   Six months
ended
June 30,
2026
Reported
   Transaction
Accounting
Adjustments
   Notes   Pro Forma 
   (Unaudited) 
                 
Research and development costs, net  $402   $(97)   A   $305 
General and administrative costs   714    (440)   A    274 
Total operating expenses   1,116    (537)        579 
                     
Operating loss   (1,116)   537         (579)
                     
Financial income (expenses), net   18    (49)   A, D    (31)
Equity in losses from investment in affiliate   -    (253)   C    (253)
                     
Loss before income tax   (1,098)   235         (863)
Tax income   70    -         70 
Net loss   (1,028)   235         (793)
                     
Net loss attributable to non-controlling interest   (78)   -         (78)
Net loss attributable to the Company   (950)   235    A, C    (715)
                     
Other comprehensive loss   (194)   184    A    (10)
Total comprehensive loss   (1,222)   419         (803)
                     
Comprehensive loss attributable to non-controlling interests   (101)   -         (101)
Comprehensive loss attributable to the Company   (1,121)   419         (702)
                     
Basic and diluted loss per common stock   (0.08)   0.02    E    (0.06)
Weighted average common stock outstanding   11,246,252    -         11,246,252 

  

4

 

CHARGING ROBOTICS INC.

Unaudited Pro Forma Interim Condensed Consolidated Statement of Comprehensive Income (Loss)
For the Year ended December 31, 2025

U.S. dollars in thousands
(Except share and per share data)

  

   Year ended December 31,
2025
   Transaction Accounting Adjustments   Notes   Pro Forma 
   (Audited)   (Unaudited) 
                 
Research and development costs, net  $652   $(281)   A   $371 
General and administrative costs   1,245    (677)   A    568 
Total operating expenses   1,897    (958)        939 
                     
Operating loss   (1,897)   958         (939)
                     
Gain on deconsolidation of subsidiary   -    4,865    B    4,865 
Other income   1,287    -         1,287 
Financial income (expenses), net   49    (33)   A, D    16 
Equity in losses from investment in affiliate   (42)   (585)    C    (627)
                     
Income (loss) before income tax   (603)   5,205         4,602 
Tax income   70    -         70 
Net income (loss)   (533)   5,205         4,672 
                     
Net loss attributable to non-controlling interest   (146)   -         (146)
Net income (loss) attributable to the Company   (387)   5,205         4,818 
                     
Other comprehensive loss   (263)   252    A    (11)
Total comprehensive income (loss)   (796)   5,457         4,661 
                     
Comprehensive loss attributable to non-controlling interests   (153)   -         (153)
Comprehensive income (loss) attributable to the Company   (643)   5,457         4,814 
                     
Basic and diluted income (loss) per common stock   (0.04)   0.5    E    0.46 
Weighted average common stock outstanding   10,509,347              10,509,347 

 

5

 

Transaction Accounting Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet

 

A.Deconsolidation of Charging Israel. Represents the derecognition of Charging Israel’s historical assets and liabilities accounts upon the Company’s loss of control.

 

Before the deconsolidation, Charging Israel transferred its 18.33% ownership interest in Revoltz to the Company. As an internal reorganization, the transfer had no effect on the consolidated financial statements. Accordingly, the deconsolidation adjustment removes Charging Israel’s assets and liabilities accounts but does not remove or otherwise change the accounting for Revoltz, which remains consolidated by the Company.

 

B.Retained 49% investment in Charging Israel. Represents the recognition of the Company’s retained 49% ownership interest in Charging Israel at fair value as of the date on which the Company ceased to have a controlling financial interest in Charging Israel, in accordance with ASC 810. The fair value of the retained interest was estimated by reference to the $2.5 million cash consideration paid by Clearmind for newly issued shares representing a 51% controlling interest in Charging Israel, with adjustments to reflect the control premium inherent in the acquired interest and the economic benefit to Charging Israel arising from the related $1.5 million loan funded by Clearmind at an interest rate below prevailing market terms. Following the loss of control, the Company accounts for its retained investment under the equity method in accordance with ASC 323. The excess of the initial carrying amount of the retained investment over the Company’s proportionate share of the carrying amount of Charging Israel’s underlying net assets is allocated to the identifiable assets and liabilities of Charging Israel based on their respective fair values, with any residual amount treated as equity-method goodwill. Such basis differences are accounted for in the Company’s subsequent recognition of equity-method earnings or losses, as applicable.

 

C.Intercompany balances and arrangements. Represents the recognition, settlement, continuation or inclusion in the deconsolidation calculation of receivables, payables, loans and other balances between the Company and Charging Israel that were eliminated in the historical consolidated financial statements. Balances settled before or at closing are removed; balances that are not settled are presented as third-party balances after deconsolidation, subject to their contractual terms and collectability.

 

6

 

Transaction Accounting Adjustments to Unaudited Pro Forma Condensed Combined Statement of Operations

 

A.Removal of Charging Israel’s historical operations. Represents the elimination of Charging Israel’s historical results from the Company’s consolidated statements of operations as if the loss of control had occurred on January 1, 2025, including its operating expenses, finance income or expense and other income or expense. Amounts attributable to Revoltz remain included because Revoltz continues to be consolidated by the Company following the internal transfer of its ownership interest.

 

B.Gain on deconsolidation. Represents the estimated gain recognized upon the loss of control of Charging Israel, measured as the difference between (i) the fair value of the retained 49% interest and (ii) the carrying amount of Charging Israel’s net assets attributable to the Company, after giving effect to the Revoltz transfer and the treatment of intercompany balances. The $2.5 million share subscription proceeds and the $1.5 million loan proceeds were received by Charging Israel and are not presented as cash received directly by the Company.

 

C.Equity-method earnings or losses of Charging Israel. Represents the Company’s 49% share of Charging Israel’s pro forma net income or loss for the periods presented. This adjustment includes 49% of the interest expense on the Clearmind loan and other recurring post-transaction effects, as applicable. No adjustment has been made for basis differences associated with the retained investment, as management believes such differences would primarily relate to non-amortizing assets.

 

D.Intercompany income and expense. Represents the reversal of historical intercompany expense, interest and other transactions between the Company and Charging Israel that will no longer be eliminated after the loss of control, together with elimination of any post-transaction intercompany amounts included in Charging Israel’s equity-method results to avoid double counting. The adjustment is limited to arrangements that continue after closing and is based on the contractual terms applicable after deconsolidation.

 

E.Net income or loss attributable to the Company and earnings per share. Represents the effect of the foregoing adjustments on pro forma net income or loss attributable to the Company and on pro forma basic and diluted earnings per share. No adjustment is made to the Company’s historical weighted-average shares outstanding because the transactions did not involve the issuance or redemption of the Company’s common shares.

 

7

 

Filing Exhibits & Attachments

6 documents

Keep reading